(Nasdaq: GILD) today announced that the European Commission (EC) has granted marketing authorization for Trodelvy ® (sacituzumab govitecan-hziy) as monotherapy for the treatment of adult patients with ...
Sellas Life Sciences stock faces downside risk ahead of REGAL Phase 3 data, and the valuation looks stretched. Click here to ...
CLL is a type of leukemia where the bone marrow makes too many white blood cells. Treatment can help to slow the progression of the cancer and ease a person’s symptoms. CLL treatments include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results